Celltex Therapeutics

What Celltex Therapeutics does

Celltex Therapeutics Corporation is a Houston, Texas-based biotechnology company founded in 2011 by David Eller and Dr. Stanley Jones that operates an FDA-registered, cGMP-compliant laboratory specializing in autologous adult adipose-derived Mesenchymal Stem Cell (MSC) banking and therapy. Using a proprietary process, the company isolates, culture-expands, and cryopreserves hundreds of millions of a client's own MSCs from a single fat-tissue sample, storing them at -300°F for lifetime therapeutic use. Therapy administration is delivered at Hospital Galenia in Cancun, Mexico under COFEPRIS oversight through Celltex Mexico, its wholly-owned subsidiary, creating a medical-tourism model for US clients.

The company markets two integrated offerings: a one-time Adult Stem Cell Banking service (with ongoing cryogenic storage fees) and an MSC Therapy service delivered via IV infusion, intraarticular, intradiscal, intrathecal, intranasal, intradermal, or nebulizer routes by licensed physicians. Celltex differentiates on dose scale (approximately 20,000x larger than same-day stem-cell therapies), a 10,000+ therapy track record with no severe adverse events reported, and reported clinical outcomes (e.g., 83% osteoarthritis symptom improvement, 100% inflammatory arthritis respondents reporting improvement). Target customers are individuals with chronic, autoimmune, neurological, orthopedic, and degenerative conditions, plus a secondary wellness/longevity segment.

The go-to-market is direct-to-consumer with a sales-assisted layer: a website funnel, free no-obligation assessment questionnaires, educational webinars, client testimonials, and a medical-professional partner program drive enrollment, while a Client Services team coordinates medical reviews and logistics. Revenue is generated through upfront banking fees, recurring storage subscriptions, and per-episode therapy charges, though pricing is not publicly disclosed. Celltex is a privately held company with 11–50 employees, a single $34M funding round disclosed in 2012, and no public financial reporting.

Name

Celltex Therapeutics

Legal name

Celltex Therapeutics Corporation

Website

https://celltexbank.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Celltex Therapeutics is a Houston-based biotechnology company that isolates, culture-expands, and cryopreserves autologous adipose-derived mesenchymal stem cells in an FDA cGMP-compliant lab, serving individuals with chronic, autoimmune, and degenerative conditions through stem cell banking and therapy administered in Cancun, Mexico.

Ownership category

akta.pro rank

Product category

Regenerative Medicine Services

NAICS

Biological Product (except Diagnostic) Manufacturing (325414), Pharmaceutical and Medicine Manufacturing (3254), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Blood and Organ Banks (621991)

SIC

Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Services-Medical Laboratories (8071)

akta.pro primary industry

Cell Therapy Developers (Autologous) (HLAAABAA)

akta.pro secondary industries

Stem Cell–Based Regenerative Therapies (HLAAAGAA), Cell Therapy Manufacturing Services (GMP, autologous/allogeneic) (HLAAAKAC), Cell Therapy Manufacturing Platforms & Automation (closed systems, bioreactors, fill-finish) (HLAAABAG), Cell Processing & Ancillary Materials (media, cytokines, beads, vectors, disposables) (HLAAABAH), Bone Marrow & Stem Cell Transplant (BMT/HSCT) (HLAKAFAI)

Keywords

• Adult stem cell banking
• Mesenchymal stem cell therapy
• Autologous MSC therapy
• Regenerative medicine services
• Adipose-derived stem cells

Headquarters

HQ city

Houston

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Others

Revenue model

1. Adult Stem Cell Banking Services: One-time adipose tissue extraction followed by MSC isolation, culture expansion, and cryopreservation for lifetime storage. Clients pay for the initial banking process and ongoing storage fees.
2. Stem Cell Therapy Services: When therapy is needed, stored MSCs are thawed and culture-expanded to therapeutic dose, then administered by licensed physicians at Hospital Galenia in Cancun, Mexico.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Celltex Therapeutics provides adult stem cell banking and therapy services using its proprietary technology to isolate, culture-expand, and cryopreserve autologous adipose-derived Mesenchymal Stem Cells (MSCs). From a single fat tissue sample, the company produces hundreds of millions of clinical-grade MSCs stored in its FDA cGMP-compliant Houston laboratory for lifetime therapeutic use. Therapy is administered by licensed physicians at Hospital Galenia in Cancun, Mexico, through multiple delivery routes including IV infusion and targeted injections.

Product overview

Celltex Therapeutics offers a unified adult stem cell banking and therapy service centered on its proprietary Mesenchymal Stem Cell (MSC) technology. The core offering consists of Adult Stem Cell Banking, which isolates, expands, and cryopreserves a client's own adipose-derived MSCs into hundreds of millions of clinical-grade cells stored for lifetime therapeutic use. This is complemented by MSC Therapy, where banked cells are administered through various routes (IV infusion, targeted injections) by licensed physicians. The company's competitive differentiator is its high-dose culture expansion process, which yields approximately 20,000x more MSCs than same-day stem cell therapies. Client Services provides ongoing support throughout the process.

Differentiator

Problem solved

Functional benefit

Products and services

• Adult Stem Cell Banking Celltex's proprietary process for isolating, culturing, and cryopreserving autologous adipose-derived Mesenchymal Stem Cells (MSCs) from a single fat tissue sample to create a lifetime stem cell bank. Cells are stored at -300°F in FDA cGMP-compliant Houston laboratory with ISO Class 7 clean room.
• MSC Therapy Therapeutic application of banked mesenchymal stem cells through various administration routes (IV infusion, intraarticular injection, intradiscal injection, intrathecal injection, intradermal injection, intranasal infusion, nebulizer infusion) performed by licensed physicians at Hospital Galenia in Cancun, Mexico. Treats conditions including autoimmune diseases, vascular diseases, degenerative diseases, and orthopedic conditions.

Quantifiable outcome

• Over 10,000 stem cell therapies administered with no severe adverse events
• +5 more outcomes

Named customers7 records

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Hospital GaleniacoreStrategic or Co-development PartnerHospital Galenia in Cancun, Quintana Roo, Mexico is the primary therapy administration site for Celltex clients. The hospital operates under COFEPRIS (Federal Commission for Protection against Sanitary Risk), Mexico's equivalent of the FDA. Celltex Mexico's team of administering physicians includes specialists in orthopedic surgery, neurosurgery, emergency medicine, and anesthesiology who perform various MSC injection and infusion methods at the hospital.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Market position

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/CelltexCorp
• YouTubevimeo.com/celltex
• Facebookfacebook.com/celltexbank
• LinkedInlinkedin.com/company/celltex-therapeutics-corporation
• Instagraminstagram.com/celltextherapeutics

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Celltex Therapeutics